|
US2015025064A1
|
|
Benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof
|
|
US2013253019A1
|
|
Lysophosphatidic acid receptor antagonists for the treatment of conditions or diseases of the eye
|
|
WO2011109679A2
|
|
Inhibitors of 5-lipoxygenase
|
|
US2012196839A1
|
|
Compounds as lysophosphatidic acid receptor antagonists
|
|
US2012184493A1
|
|
Dermal formulations of dp2 receptor antagonists
|
|
US2012027842A1
|
|
Topical formulations of flap inhibitors for administration to an eye
|
|
US2011301134A1
|
|
Alkyne antagonists of lysophosphatidic acid receptors
|
|
US2011245303A1
|
|
Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors
|
|
US2010004331A1
|
|
Antagonists of prostaglandin D2 receptors
|
|
US2011021573A1
|
|
Antagonists of prostaglandin D2 receptors
|
